BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 38635387)

  • 1. Prognosis Prediction of Diffuse Large B-cell Lymphoma in
    Qian C; Jiang C; Xie K; Ding C; Teng Y; Sun J; Gao L; Zhou Z; Ni X
    IEEE J Biomed Health Inform; 2024 Apr; PP():. PubMed ID: 38635387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of
    Geng H; Lian K; Zhang W
    Quant Imaging Med Surg; 2024 Jan; 14(1):325-334. PubMed ID: 38223089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiomics signature from [
    Jiang C; Huang X; Li A; Teng Y; Ding C; Chen J; Xu J; Zhou Z
    Eur Radiol; 2022 Aug; 32(8):5730-5741. PubMed ID: 35298676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal PET-based radiomic signature construction based on the cross-combination method for predicting the survival of patients with diffuse large B-cell lymphoma.
    Jiang C; Li A; Teng Y; Huang X; Ding C; Chen J; Xu J; Zhou Z
    Eur J Nucl Med Mol Imaging; 2022 Jul; 49(8):2902-2916. PubMed ID: 35146578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deep learning-based tumour segmentation and total metabolic tumour volume prediction in the prognosis of diffuse large B-cell lymphoma patients in 3D FDG-PET images.
    Jiang C; Chen K; Teng Y; Ding C; Zhou Z; Gao Y; Wu J; He J; He K; Zhang J
    Eur Radiol; 2022 Jul; 32(7):4801-4812. PubMed ID: 35166895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of metabolic tumour volume on baseline
    Shagera QA; Cheon GJ; Koh Y; Yoo MY; Kang KW; Lee DS; Kim EE; Yoon SS; Chung JK
    Eur J Nucl Med Mol Imaging; 2019 Jul; 46(7):1417-1427. PubMed ID: 30941463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Baseline
    Jing F; Liu Y; Zhao X; Wang N; Dai M; Chen X; Zhang Z; Zhang J; Wang J; Wang Y
    EJNMMI Res; 2023 Oct; 13(1):92. PubMed ID: 37884763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Machine learning in the differentiation of follicular lymphoma from diffuse large B-cell lymphoma with radiomic [
    de Jesus FM; Yin Y; Mantzorou-Kyriaki E; Kahle XU; de Haas RJ; Yakar D; Glaudemans AWJM; Noordzij W; Kwee TC; Nijland M
    Eur J Nucl Med Mol Imaging; 2022 Apr; 49(5):1535-1543. PubMed ID: 34850248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a radiomic-clinical nomogram for prediction of survival in patients with diffuse large B-cell lymphoma treated with chimeric antigen receptor T cells.
    Zhou Y; Zhang B; Han J; Dai N; Jia T; Huang H; Deng S; Sang S
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):11549-11560. PubMed ID: 37395846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Robust deep learning-based PET prognostic imaging biomarker for DLBCL patients: a multicenter study.
    Jiang C; Qian C; Jiang Z; Teng Y; Lai R; Sun Y; Ni X; Ding C; Xu Y; Tian R
    Eur J Nucl Med Mol Imaging; 2023 Nov; 50(13):3949-3960. PubMed ID: 37606859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stacking Ensemble Learning-Based [
    Zhao S; Wang J; Jin C; Zhang X; Xue C; Zhou R; Zhong Y; Liu Y; He X; Zhou Y; Xu C; Zhang L; Qian W; Zhang H; Zhang X; Tian M
    J Nucl Med; 2023 Oct; 64(10):1603-1609. PubMed ID: 37500261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multimodal deep learning model on interim [
    Yuan C; Shi Q; Huang X; Wang L; He Y; Li B; Zhao W; Qian D
    Eur Radiol; 2023 Jan; 33(1):77-88. PubMed ID: 36029345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel analytic approach for outcome prediction in diffuse large B-cell lymphoma by [
    Zhang X; Chen L; Jiang H; He X; Feng L; Ni M; Ma M; Wang J; Zhang T; Wu S; Zhou R; Jin C; Zhang K; Qian W; Chen Z; Zhuo C; Zhang H; Tian M
    Eur J Nucl Med Mol Imaging; 2022 Mar; 49(4):1298-1310. PubMed ID: 34651227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of Overall Survival and Progression-Free Survival by the
    Zhou Y; Ma XL; Pu LT; Zhou RF; Ou XJ; Tian R
    Contrast Media Mol Imaging; 2019; 2019():5963607. PubMed ID: 31777473
    [No Abstract]   [Full Text] [Related]  

  • 15. [
    Xu HQ; Song LJ; Ding CY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Dec; 31(6):1690-1700. PubMed ID: 38071047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Value of Baseline Radiomic Features of
    Lue KH; Wu YF; Lin HH; Hsieh TC; Liu SH; Chan SC; Chen YH
    Diagnostics (Basel); 2020 Dec; 11(1):. PubMed ID: 33379166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [
    Travaini LL; Botta F; Derenzini E; Lo Presti G; Ferrari ME; Airò Farulla LS; Radice T; Mazzara S; Tarella C; Pileri S; Raimondi S; Ceci F
    Hematol Oncol; 2023 Oct; 41(4):674-682. PubMed ID: 37209024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deep-Learning
    Capobianco N; Meignan M; Cottereau AS; Vercellino L; Sibille L; Spottiswoode B; Zuehlsdorff S; Casasnovas O; Thieblemont C; Buvat I
    J Nucl Med; 2021 Jan; 62(1):30-36. PubMed ID: 32532925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor Location Relative to the Spleen Is a Prognostic Factor in Lymphoma Patients: A Demonstration from the REMARC Trial.
    Girum KB; Cottereau AS; Vercellino L; Rebaud L; Clerc J; Casasnovas O; Morschhauser F; Thieblemont C; Buvat I
    J Nucl Med; 2024 Feb; 65(2):313-319. PubMed ID: 38071535
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Girum KB; Rebaud L; Cottereau AS; Meignan M; Clerc J; Vercellino L; Casasnovas O; Morschhauser F; Thieblemont C; Buvat I
    J Nucl Med; 2022 Dec; 63(12):1925-1932. PubMed ID: 35710733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.